SARS-CoV-2 mRNA vaccine candidate encoding RBD chimera of Delta and Omicron variants: immunogenic potential and validation
Because of its ability to target immune cells, the mRNA vaccine candidate can potentially improve immune responses against circulating or emerging variants.
Authors
- Ashraf Mohammadi (ORCID: https://orcid.org/0000-0001-5744-767X)
- Sina Soleimani (ORCID: https://orcid.org/0000-0002-3914-2909)
- Abbas Zare Mirakabadi (ORCID: https://orcid.org/0000-0003-3354-1543)
- Shahla Shahsavandi (ORCID: https://orcid.org/0000-0002-9599-6722)
- Mojtaba Noofeli (ORCID: https://orcid.org/0000-0003-4991-4631)
- Majid Tebyanian
- Amir Ali Hariri
- Mohammad Mehdi Ranjbar (ORCID: https://orcid.org/0000-0001-8611-5762)
- Zarrin Sharifnia
Institutions
- Razi Vaccine and Serum Research Institute (IR)
- Isfahan Fertility and Infertility Center (IR)
- Agricultural Research & Education Organization (IR)
Publication Details
- Journal
- Iranian Journal of Microbiology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.18502/ijm.v17i5.19891
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00